Mölnlycke Establishes Wound Care Factory in China for Growth

Mölnlycke Health Care is building its first wound care factory in China. The 10,000-square-meter facility in Changshu will produce Mepilex wound care products, with production starting in late 2026 or early 2027. Mölnlycke Health Care is establishing its inaugural wound care product manufacturing facility in China, according to Medtech Magazine. The 10,000-square-meter facility, located in Changshu, eastern China, aligns with the company’s strategy to localize production for key markets. The factory will produce wound care solutions from the Mepilex series. Production is slated to commence in late 2026 or.